The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from Business Wire

Teva to Present at the 2013 RBC Capital Markets Global Healthcare Conference

Monday, February 25, 2013

Teva to Present at the 2013 RBC Capital Markets Global Healthcare Conference12:47 EST Monday, February 25, 2013 JERUSALEM (Business Wire) -- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio webcast at the 2013 RBC Capital Markets Global Healthcare Conference. Jon Congleton, SVP, Global Medicines Group, will present on Wednesday, February 27, 2013. What:   Teva Presentation at the 2013 RBC Capital Markets Global Healthcare Conference   Who: Jon Congleton, SVP, Global Medicines Group   When: Wednesday, February 27 2013 at 1:30 PM (EST)   Where: www.tevapharm.com or http://www.veracast.com/webcasts/rbc/healthcare2013/38211345.cfm   How: Live over the Internet – log on to the Web at the address above and register for the event (approximately 10 minutes before). An archive of the webcast will be available on Teva's website. About Teva Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,000 molecules and a direct presence in about 60 countries. Teva's branded businesses focus on CNS, oncology, pain, respiratory and women's health therapeutic areas as well as biologics. Teva currently employs approximately 46,000 people around the world and reached $20.3 billion in net revenues in 2012. Teva Pharmaceutical Industries Ltd.IR:Kevin C. MannixUnited States215-591-8912orKristen FrankUnited States215-591-8908orTomer AmitaiIsrael972 (3) 926-7656orPR:Hadar Vismunski-WeinbergIsrael972 (3) 926-7687orDenise BradleyUnited States215-591-8974